Silo Pharma (SILO) Divestments (2019 - 2021)
Silo Pharma (SILO) posted Divestments of $284456.0 for Q4 2021, up 113.96% sequentially from $132951.0 in Q3 2019.
Silo Pharma (SILO) Divestments (2019 - 2021) Analysis & Trends
Silo Pharma has reported Divestments for 2 years, with the latest figure at $284456.0 in Q4 2021.
- Quarterly Divestments changed N/A year-over-year to $284456.0 in Q4 2021, while the trailing twelve-month figure through Dec 2022 was $284456.0 (changed N/A YoY) and the FY2022 annual result came in at $66707.0, down 99.05% from the prior year.
- Divestments rose to $284456.0 in Q4 2021 per SILO's latest filing, from $132951.0 in the prior quarter.
- Over five years, Divestments peaked at $284456.0 in Q4 2021 and troughed at $132951.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -13.21 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Silo Pharma | 3.04 Mn | 3.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 284,456.00 |
| Sep 30, 2019 | 132,951.00 |